Improving Market Share by Increasing Staffing in the CSO Business

「In the CSO business, the number of companies using dispatched MRs increased at アポプラスステーション株式会社, and the number of dispatched MRs rose as a result of appropriately responding to corporate demand. Going forward, the company will strengthen its recruiting capabilities by enhancing cooperation with staffing and placement companies, among other measures, and will undertake sales activities in various fields aligned with advances in healthcare.」

「In the CSO business, the number of dispatched MRs increased as demand for MR dispatch services expanded, while recruitment costs also increased. Going forward, to meet the diversifying needs of medical professionals, the company will recruit personnel with broad experience, focus on developing specialized-area MRs, and undertake sales activities in various fields aligned with advances in healthcare.」

「In the CSO business, the number of dispatched MRs increased as demand for MR dispatch services expanded, while recruitment costs also increased. To continue increasing the number of dispatched MRs and meet the diversifying needs of medical professionals, the company will focus on recruiting personnel with broad experience and providing high-quality education, including specialized-area MR training programs. It has also begun marketing MR training externally to pharmaceutical companies, leveraging its accumulated expertise in MR development.」

「In the CSO business, the company is focusing on developing high-quality personnel sought by medical professionals to meet growing demand for MR dispatch services, including by strengthening recruitment of personnel with broad experience, expanding training programs for specialized-area MRs, and improving quality through continuing education.」

「In the CSO business, the company is focusing on developing high-quality personnel sought by medical professionals to meet growing demand for MR dispatch services, including by strengthening recruitment of personnel with broad experience, expanding training programs for specialized-area MRs, and improving quality through continuing education.」

「In the CSO business, demand for MR dispatch services has steadily increased since April 2021. The company will continue to focus on developing high-quality personnel sought by medical professionals, including by expanding training programs for specialized-area MRs, strengthening recruitment of personnel with broad experience, and improving quality through continuing education.」

「In the CSO business, demand for MR dispatch services has steadily increased since April 2021. The company is continuing to focus on developing high-quality personnel sought by medical professionals, including by expanding training programs for specialized-area MRs, strengthening recruitment of personnel with broad experience, and improving quality through continuing education.」

「In its CSO business, the company is focusing on developing talented personnel sought by the medical field, including expanding training programs for specialist-area medical representatives, strengthening the recruitment of personnel with broad experience, and improving quality through ongoing education.」

「In the CSO business, the company has established an in-house certification system and provides training by therapeutic area and e-learning, among other initiatives, focusing on developing CMRs sought by medical professionals. Going forward, it will continue to propose measures suited to the post-pandemic era, leveraging its highly specialized CMRs and sales capabilities with pharmaceutical companies as strengths.」

「In the CSO business, the company has established an in-house certification system and provides training by therapeutic area and e-learning, among other initiatives, focusing on enhancing expertise and added value.」

「In the CSO business, demand from pharmaceutical manufacturers for CMRs (contract MRs) is increasing. The group is also focusing on enhancing expertise, which has raised the per-person staffing rate. Going forward, it will continue to propose initiatives suited to the era of living with COVID-19, leveraging its highly specialized CMRs and sales capabilities with pharmaceutical companies.」

「The external environment for the group’s core CSO business is characterized by growing demand from pharmaceutical manufacturers for CMRs (contract MRs). Against this backdrop, the group has maintained the industry’s highest number of contracts through its ongoing efforts to train highly specialized CMRs and actively market to pharmaceutical companies. CMR orders are also increasing, and the group is working to strengthen recruitment.」

「Orders for MRs are also increasing, and the company is working to strengthen recruitment.」

「Through its ongoing efforts to train highly specialized MRs and actively market to pharmaceutical companies, the group has maintained the industry’s highest number of contracts while increasing the number of MR contracts.」

「Within the group's BPO business, the CSO business, which is core to アポプラスステーション株式会社, is training highly specialized MRs and actively pursuing sales to pharmaceutical companies. The number of MR contracts is increasing while the company maintains the industry's largest number of client companies under contract.」

「Despite the MR dispatch market's downward trend, the company continues to maintain the industry's largest number of client companies under contract. It is also training highly specialized MRs and strengthening sales to pharmaceutical companies, and the number of dispatched MRs is progressing as planned.」

「In the CSO business, the company continues to maintain the industry's largest number of client companies under contract despite the MR dispatch market's downward trend. It is also training highly specialized MRs and strengthening sales to pharmaceutical companies to develop new customers and extend contracts for existing projects.」

「The group is also working to train highly specialized MRs and strengthen sales efforts directed at pharmaceutical companies to develop new customers and extend contracts for existing engagements.」

「The number of orders for MR dispatch services is progressing as planned, and the company continues to have the largest number of contracts with pharmaceutical companies in the industry. It is also training highly specialized MRs and strengthening sales efforts to pharmaceutical companies to develop new customers and extend contracts for existing projects. In the staffing and placement business, the number of dispatched pharmacists and other personnel has increased and business remains firm. The company has also opened a new sales office to expand the business.」

「Orders for MR staffing are progressing as planned, and the number of contracts with pharmaceutical companies remains the highest in the industry. The group is also training highly specialized MRs and strengthening sales efforts directed at pharmaceutical companies to develop new customers and extend contracts for existing engagements.」

「To acquire new customers and extend existing contracts, the Company is developing highly specialised MRs and strengthening sales efforts to pharmaceutical companies. In the temporary staffing and placement business, the number of dispatched pharmacists and other personnel increased, and performance remained solid. The Company has also opened a new sales office to expand the business.」

「The CSO business grew steadily, and performance progressed smoothly alongside the strong temporary staffing and placement business. As a result, revenue increased by ¥1,256 million year on year to ¥10,905 million, up 13.0% year on year, while operating profit increased by ¥498 million to ¥1,498 million, up 49.8%.」

「The CSO business grew steadily, and performance progressed smoothly alongside the strong temporary staffing and placement business. As a result, revenue increased by ¥1,210 million year on year to ¥8,208 million, up 17.3% year on year, while operating profit increased by ¥375 million to ¥1,154 million, up 48.1%.」

「In the CSO business, the Company is working to increase market share by expanding its workforce, and performance has progressed steadily alongside the strong staffing business. As a result, revenue increased by ¥884 million year on year to ¥5,492 million, up 19.2% year on year, while operating profit increased by ¥266 million to ¥791 million, up 50.8%.」

「In the CSO business, the Company is working to increase market share by expanding its workforce, and performance has progressed steadily alongside the strong temporary staffing and placement business. As a result, revenue increased by ¥492 million year on year to ¥2,767 million, up 21.7% year on year, while operating profit increased by ¥169 million to ¥459 million, up 58.4%.」